Ellex announces further positive clinical and scientific results for 2RT treatment of early AMD

Ellex today announced the 24-month follow up of the pilot study to investigate the efficacy of the Company’s proprietary Retinal Rejuvenation Therapy (2RT™) in the treatment of early Age-Related Macular Degeneration (AMD) has been released and published in a summary form at the recent Association for Research in Vision and Ophthalmology (ARVO) 2014 conference in Orlando, Florida.
Read More